Ashley Krull, PhD Contributing Editor, ISCT Telegraft The Ohio State University United States The 2025 Cell Therapy Leadership Training Program - ISCT Workforce Development brought together 15 scholars from around the world for an intensive week of lectures, case studies, mentorship, and...
Travis Byrd, PhD Junior Associate Editor, ISCT Telegraft The Ohio State University Wexner Medical Center United States Earlier this month, I attended a local immuno-oncology symposium as a representative of our cell therapy lab’s process development team. I presented a poster showcasing some...
Miguel Forte, MD, PhD ISCT President Kiji Therapeutics Belgium In several European countries children know that at the end of the year, there is an appraisal on how well they behaved over the past year. It is the tradition of Saint Nicholas and Chimney Pete on the 6th of December. Depending...
Ashley Krull, PhD ISCT Lab Practices Committee Co-Chair Contributing Editor, ISCT Telegraft James Cancer Hospital Cellular Therapy Laboratory The Ohio State University United States Lynn O’Donnell, PhD W.W. Williams Cell Therapy Laboratory The Ohio State University United States The United...
Tongted Das, PhD Monash Health Australia Jessica Sue, BSc, MHSM Junior Associate Editor, ISCT Telegraft Sydney Cord Blood Bank Sydney Children's Hospital Network Australia ISCT Representation in Recent Regulatory Work (Australia) The ISCT committee participated in the following...
Adam Lee, MS Thermo Fisher Scientific United States Kevin Bosse, PhD Nationwide Children’s Hospital United States A Look at the FDA's New Plausible Mechanism Pathway for Bespoke Therapies Top FDA officials, Vinay Prasad and Martin Makary, authored an article in the New England...
Fajar Dumadi, BSc ISCT Canada Committee for Advanced Therapies (CAT) Agendas for recent meetings Agenda for CAT workshop on gene editing on 16 September 2025 https://www.ema.europa.eu/en/documents/agenda/agenda-committee-advanced-therapies-cat-workshop-gene-editing en.pdf ...
Adaeze Ekwe, PhD Junior Associate Editor, ISCT Telegraft Queensland University of Technology (QUT) Australia A Cell Therapy Pioneer and Mentor Dr. Malcolm Brenner has been a cornerstone in bringing gene and cell therapies from aspiration to routine clinical practice. Grounded in rigorous...
By the ISCT Business Development & Finance Committee With investment activity fluctuating across the cell and gene therapy sector, access to timely financing and M&A insights is essential for organizations to stay informed and ahead of the curve. The ISCT Business Development &...
David Moolten, MD Medical Director American Red Cross United States Why the Quality and Make-up of Starting Material Matters The familiar truism garbage in, garbage out can be ruinously accurate in the setting of cell and gene therapy production. What is in the bag at the beginning...